You are here

Lutonix

CR Bard’s Lutonix wins Medicare reimbursement add-on

CR Bard’s Lutonix wins Medicare reimbursement add-on

Mass Device

Flag link:

Bard touts 2-year data on Lutonix

Bard touts 2-year data on Lutonix

Mass Device

drug-coated balloons

Flag link:

Boston Scientific to sell Bard's Lutonix balloon

Boston Scientific to sell Bard's Lutonix balloon

Mass Device

Boston Scientific

peripheral artery disease

Flag link:

First of Its Kind Study Design Raises the Bar for Scientific Rigor in Drug-Coated Balloons

First of Its Kind Study Design Raises the Bar for Scientific Rigor in Drug-Coated Balloons

Yahoo

drug-coated balloons

peripheral artery disease

Flag link:

Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial

Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial

Yahoo/BusinessWire

clinical trials

Flag link:

Bard to buy Lutonix for $225 million

Bard to buy Lutonix for $225 million

Flag link: